Addressing unmet needs for inherited neuromuscular diseases
Addressing unmet needs for inherited neuromuscular diseases
angilma1
Thu, 11/21/2024 – 12:45
Read more about Addressing unmet needs for inherited neuromuscular diseases
PrintPDF
Entries by angilma1
Negative impact of the IRA on patient access to innovative treatments
Negative impact of the IRA on patient access to innovative treatments
angilma1
Thu, 08/15/2024 – 14:46
Read more about Negative impact of the IRA on patient access to innovative treatments
PrintPDF
Negative impact of the IRA on patient access to innovative treatments
Negative impact of the IRA on patient access to innovative treatments
angilma1
Thu, 08/15/2024 – 14:46
Read more about Negative impact of the IRA on patient access to innovative treatments
PrintPDF
Novartis statement on Maximum Fair Price for Entresto
Novartis statement on Maximum Fair Price for Entresto
angilma1
Thu, 08/15/2024 – 14:36
Read more about Novartis statement on Maximum Fair Price for Entresto
PrintPDF
Novartis statement on Maximum Fair Price for Entresto
Novartis statement on Maximum Fair Price for Entresto
angilma1
Thu, 08/15/2024 – 14:36
Read more about Novartis statement on Maximum Fair Price for Entresto
PrintPDF
Novartis Financial Results – Q2 2024
Novartis Financial Results – Q2 2024
angilma1
Mon, 07/15/2024 – 11:49
Read more about Novartis Financial Results – Q2 2024
PrintPDF
A legacy of blood cancer innovation
A legacy of blood cancer innovation
angilma1
Fri, 05/31/2024 – 18:01
Read more about A legacy of blood cancer innovation
PrintPDF
A legacy of blood cancer innovation
A legacy of blood cancer innovation
angilma1
Fri, 05/31/2024 – 18:01
Read more about A legacy of blood cancer innovation
PrintPDF
Novartis receives FDA Breakthrough Therapy designation for Scemblix® in 1L CML
Novartis receives FDA Breakthrough Therapy designation for Scemblix® in 1L CML
angilma1
Fri, 05/10/2024 – 10:14
Read more about Novartis receives FDA Breakthrough Therapy designation for Scemblix® in 1L CML
PrintPDF
Novartis Financial Results – Q1 2024
Novartis Financial Results – Q1 2024
angilma1
Thu, 04/18/2024 – 09:55
Read more about Novartis Financial Results – Q1 2024
PrintPDF
